Aeluma (ALMU) 10-Q 14 Nov 22 2023 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Sep. 30, 2022	Nov. 10, 2022
Document Information Line Items
Entity Registrant Name	Aeluma, Inc.
Trading Symbol	NA
Document Type	10-Q
Current Fiscal Year End Date	--06-30
Entity Common Stock, Shares Outstanding		10,800,002
Amendment Flag	false
Entity Central Index Key	0001828805
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2022
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-56218
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-2807351
Entity Address, Address Line One	27 Castilian Drive
Entity Address, City or Town	Goleta
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	93117
City Area Code	(805)
Local Phone Number	351-2707
Title of 12(g) Security	None
Security Exchange Name	NONE
Entity Interactive Data Current	Yes

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Sep. 30, 2022	Jun. 30, 2022
Current assets:
Cash	$ 2,371,323	$ 3,740,722
Deferred compensation, current portion	698,521	662,464
Prepaids & other current assets	313,232	27,662
Total current assets	3,383,076	4,430,848
Property and equipment:
Equipment	624,439	619,613
Leasehold improvements	512,196	464,362
Accumulated depreciation	(135,745)	(96,987)
Total fixed assets	1,000,890	986,988
Intangible assets	12,083	12,833
Right of use asset - facility	445,140	476,370
Deferred compensation, long term portion		11,034
Other assets	13,014	13,014
Total assets	4,854,203	5,931,087
Current liabilities:
Accounts payable	179,941	114,100
Accrued expenses & other current liabilities	457,506	101,351
Lease liability, current portion	158,284	156,988
Total current liabilities	795,731	372,439
Lease liability, long term portion	418,480	458,705
Commitments and contingencies
Total liabilities	1,214,211	831,144
Stockholders’ equity:
Preferred stock, par value $0.0001, 10,000,000 authorized, none issued and outstanding.
Common stock, par value $0.0001, and 50,000,000 shares authorized, 10,650,002 shares issued and outstanding at September 30, 2022 and June 30, 2022.	1,066	1,066
Additional paid-in capital	8,851,451	8,781,361
Accumulated deficit	(5,212,525)	(3,682,484)
Total stockholders’ equity	3,639,992	5,099,943
Total liabilities and stockholders’ equity	$ 4,854,203	$ 5,931,087

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Sep. 30, 2022	Jun. 30, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	10,650,002	10,650,002
Common stock, shares outstanding	10,650,002	10,650,002

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenue
Operating expenses:
Research & development	629,456	98,445
General & administrative	696,670	402,778
Facility	144,056	111,414
Insurance	96,505	82,139
Total expenses	1,566,687	694,776
Loss from operations	(1,566,687)	(694,776)
Other income:
Sub-lease rental income & other income	36,351	90,352
Interest income	295	774
Total other income	36,646	91,126
Loss before provision for income tax	(1,530,041)	(603,650)
Provision for income tax
Net loss	$ (1,530,041)	$ (603,650)
Basic and diluted loss per share (in Dollars per share)	$ (0.14)	$ (0.06)
Weighted average common shares outstanding - basic and diluted (in Shares)	10,650,002	10,650,002

Consolidated Statements of Op_2

Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Basic and diluted loss per share (in Dollars per share)	$ (0.14)	$ (0.06)
Weighted average common shares outstanding - basic and diluted	10,650,002	10,650,002

Consolidated Statement of Stock

Consolidated Statement of Stockholders’ Equity - USD ($)	Common Stock	Additional Paid-in capital	Accumulated Deficit	Total
Balance at Jun. 30, 2021	$ 1,054	$ 8,415,432	$ (230,922)	$ 8,185,564
Balance (in Shares) at Jun. 30, 2021	10,535,002
Issuance of shares of common stock	$ 12	206,918		206,930
Issuance of shares of common stock (in Shares)	115,000
Other offering costs		(45,000)		(45,000)
Stock-based compensation		29,668		29,668
Net loss			(603,650)	(603,650)
Balance at Sep. 30, 2021	$ 1,066	8,607,018	(834,572)	7,773,512
Balance (in Shares) at Sep. 30, 2021	10,650,002
Balance at Jun. 30, 2022	$ 1,066	8,781,361	(3,682,484)	5,099,943
Balance (in Shares) at Jun. 30, 2022	10,650,002
Stock-based compensation		70,090		70,090
Net loss			(1,530,041)	(1,530,041)
Balance at Sep. 30, 2022	$ 1,066	$ 8,851,451	$ (5,212,525)	$ 3,639,992
Balance (in Shares) at Sep. 30, 2022	10,650,002

Consolidated Statement of Sto_2

Consolidated Statement of Stockholders’ Equity (Parentheticals)	3 Months Ended
	Sep. 30, 2021 USD ($)
Statement of Stockholders' Equity [Abstract]
Net of in offering costs	$ 23,070

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating activities:
Net loss	$ (1,530,041)	$ (603,650)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of deferred compensation	(25,023)	165,162
Partial refund of facility lease deposit		52,055
Stock based compensation expense	70,090	29,668
Depreciation and amortization expense	39,508
Change in prepaids & other current assets	(285,570)	(210,622)
Change in accounts payable	65,841	(46,732)
Change in accrued expenses & other current liabilities	348,456	122,067
Net cash used in operating activities	(1,316,739)	(492,052)
Investing activities:
Purchase of equipment & CIP	(4,826)	(117,342)
Payment for leasehold improvements	(47,834)	(141,568)
Net cash used in investing activities	(52,660)	(258,910)
Financing activities:
Proceeds from Private Placement, net of offering costs		206,930
Payment of other offering costs		(45,000)
Net cash provided by financing activities		161,930
Net change in cash	(1,369,399)	(589,032)
Cash, beginning of period	3,740,722	6,787,250
Cash, end of period	$ 2,371,323	$ 6,198,218

The Company

The Company	3 Months Ended
	Sep. 30, 2022
The Company [Abstract]
The Company	Note 1 – The Company Aeluma is headquartered in Goleta, California. The Company is engaged in the research and development of infrared (IR) optical sensors to disrupt the market for IR sensors, and using its proprietary technology aims to produce a much higher performance alternative to today’s low-cost sensors at much lower prices than would otherwise be possible. The focus of the Company will be the image sensor market. Initial efforts hope to penetrate the 3D imaging and sensing (mobile and consumer, defense and aerospace, industrial, medical, auto) and LiDAR (robotic vehicles, advanced driver assistance systems vehicles (ADAS), topography, wind, industrial) markets. We were originally incorporated as Parc Investments, Inc. in the State of Delaware on August 21, 2020. Prior to the Merger (as defined below), we were a “shell company” (as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). On June 22, 2021, our board of directors and all of our pre-Merger stockholders approved a restated certificate of incorporation, which was effective upon its filing with the Secretary of State of the State of Delaware on June 22, 2021 and through which we changed our name to “Aeluma, Inc.” On June 22, 2021, our board of directors also adopted restated bylaws. On June 22, 2021, Biond Photonics, Inc., a privately held California corporation (“Biond Photonics”) merged with and into our wholly-owned subsidiary, Aeluma Operating Co., a corporation formed in the State of Delaware on June 22, 2021 (“Acquisition Sub”). Pursuant to this transaction (the “Merger”), Acquisition Sub was the surviving corporation and remained our whollyowned subsidiary, and all the outstanding stock of Biond Photonics was converted into shares of our common stock. As a result of the Merger, we acquired the business of Biond Photonics and continued the existing business operations of Biond Photonics as a public reporting company under the name Aeluma, Inc. In conjunction with the merger transaction, the company changed its year end to June 30. Biond Photonics was incorporated in February 2019. Merger Agreement On June 22, 2021, Parc Investments, Inc., Acquisition Sub and Biond Photonics entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, on June 22, 2021 (the “Closing Date”), Biond Photonics merged with and into Acquisition Sub, with Acquisition Sub continuing as the surviving corporation and our wholly-owned subsidiary. As a result of the Merger, we acquired the business of Biond Photonics, a California corporation, doing business as Aeluma. At the time the certificates of merger reflecting the Merger were filed with the Secretaries of State of California and Delaware (the “Effective Time”), each of Biond Photonics’ shares of capital stock issued and outstanding immediately prior to the closing of the Merger was converted into the right to receive (a) 1.299135853 shares of our common stock (the “Common Share Conversion Ratio”), with the maximum number of shares of our common stock issuable to the former holders of Biond Photonics’ capital stock equal to 4,100,000 after adjustments due to rounding for fractional shares. Immediately prior to the Effective Time, an aggregate of 2,500,000 shares of our common stock owned by our stockholders prior to the Merger were forfeited and cancelled (the “Stock Forfeiture”). The issuance of shares of our common stock to Biond Photonics’ former security holders are collectively referred to as the “Share Conversion.” The Merger Agreement contained customary representations and warranties and pre- and post-closing covenants of each party and customary closing conditions. As a condition to the Merger, we entered into an indemnity agreement with our former officer and directors (the “Pre-Merger Indemnity Agreement”), pursuant to which we agreed to indemnify such former officer and directors for actions taken by them in their official capacities relating to the consideration, approval and consummation of the Merger and certain related transactions. The Merger was treated as a recapitalization and reverse acquisition for financial reporting purposes. Biond Photonics is considered the acquirer for accounting purposes, and our historical financial statements before the Merger will be replaced with the historical financial statements of Biond Photonics before the Merger in future filings with the SEC. The Merger is intended to be treated as a tax-free reorganization under Section 368(a) of the Internal Revenue Code of 1986, as amended. Change of Fiscal Year On June 30, 2021, we changed our fiscal year from the period beginning on January 1 and ending on December 31 to the period beginning on July 1 and ending on June 30 of each year.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 – Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited interim consolidated financial statements have been presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and the instructions to Article 8 of Regulation S-X. Accordingly, the financial statements do not include all of the information and notes required by GAAP for complete financial statements. The consolidated financial statements as of September 30, 2022 and 2021, are unaudited; however, in the opinion of management such interim condensed consolidated financial statements reflect all adjustments, consisting solely of normal recurring adjustments, necessary for a fair presentation of the results for the periods presented. The accompanying financial information should be read in conjunction with the financial statements and the notes thereto in the Company’s most recent Annual Report on Form 10-K, as filed with the Securities and Exchange Commission (the “SEC”) on September 28, 2022. The results of operations for the period presented are not necessarily indicative of the results that might be expected for future interim periods or for the full year. The summary of significant accounting policies presented below is designed to assist in understanding the Company’s financial statements. Such financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. Going Concern The Company incurred a net loss of $3,451,699 and $1,530,041 for the year ended June 30, 2022 and the three months ended September 30, 2022, respectively. In addition, the Company is in the research and development stage and has not generated revenue to date. In order to support its operations, the Company will require additional infusions of cash from the sale of equity instruments or the issuance of debt instruments, or the commencement of profitable revenue generating activities. If adequate funds are not available or are not available on acceptable terms, the Company’s ability to fund its operations, develop or enhance its sensors in the future or respond to competitive pressures would be significantly limited. Such limitations could require the Company to curtail, suspend or discontinue parts of its business plan. These conditions may raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that could result from the outcome of this uncertainty. The financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. Basic Net Loss Per Share Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. The number of shares prior to the merger have been restated to consider the conversion into the shares of the legal acquirer. Use of Estimates and Assumptions The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Reclassification of Prior Year Presentation Certain prior year amounts have been reclassified for consistency with the current year presentation. Fair Value of Financial Instruments As defined in Financial Accounting Standards Board (“FASB”) ASC Topic No. 820, “Fair Value Measurements and Disclosures” (“ASC 820”), fair value is the price that would be received to sell an asset or paid to transfer the liability in an orderly transaction between market participants at the measurement date. In determining fair value, the Company uses the market or income approach. Based on this approach, the Company utilizes certain assumptions about the risk inherent in the inputs to the valuation technique. These inputs can be readily observable, market-corroborated or generally unobservable inputs. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. Based on the observability of the inputs used in the valuation techniques, the Company is required to provide the following information according to the fair value hierarchy. The fair value hierarchy ranks the quality and the reliability of the information used to determine fair values. As a basis for considering these assumptions, ASC 820 defines a three-tier value hierarchy that prioritizes the inputs used in the valuation methodologies in measuring fair value. Level 1 – Unadjusted quoted prices in active, accessible market for identical assets or liabilities Level 2 – Other inputs that are directly or indirectly observable in the marketplace Level 3 – Unobservable inputs which are supported by little or no market activity The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The carrying values of the Company’s cash, accounts payable, and accrued expenses approximate their fair value due to the relatively short maturity of these items. Concentration of Risk The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. Property and Equipment Property, equipment and leasehold improvements are reported at historical cost, net of accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the remaining lease term. Repairs and maintenance to these assets are charged to expense as incurred; major improvements enhancing the function and/or the asset’s useful life are capitalized. When items are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gains or losses arising from such transactions are recognized. Intangible Assets Intangible assets are associated with the Aeluma.com domain name and are amortized on a straight-line basis over 10 years. Cash and Cash Equivalents The Company considers cash in banks, deposits in transit, and highly liquid debt instruments purchased with original maturities of three months or less to be cash and cash equivalents. The Company’s accounts are insured by the FDIC but at times may exceed federally insured limits. Income Taxes The Company is expected to have net operating loss carryforwards that it can use to offset a certain amount of taxable income in the future. The Company is currently analyzing the amount of loss carryforwards that will be available to reduce future taxable income. The resulting deferred tax assets will be offset by a valuation allowance due to the uncertainty of its realization. The primary difference between income tax expense attributable to continuing operations and the amount of income tax expense that would result from applying domestic federal statutory rates to income before income taxes relates to the recognition of a valuation allowance for deferred income tax assets. The Company has adopted FASB ASC 740-10, “ Income Taxes” The Company will file tax returns in the U.S. federal jurisdiction and the state of California. The Company’s federal and state return form are subject to review by the taxing authorities. The Company is not currently under examination by any taxing authority, nor has it been notified of an impending examination. Stock-Based Compensation The Company accounts for stock-based compensation arrangements in accordance with guidance issued by the FASB, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, consultants, and directors based on estimated fair values. The Company estimates the fair value of stock-based compensation awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company’s statements of operations. The Company estimates the fair value of stock-based compensation awards using the Black-Scholes model. This model requires the Company to estimate the expected volatility and value of its common stock and the expected term of the stock options, all of which are highly complex and subjective variables. For employees and directors, the expected life was calculated based on the simplified method as described by the SEC Staff Accounting Bulletin No. 110, Share-Based Payment. For other service providers, the expected life was calculated using the contractual term of the award. The Company’s estimate of expected volatility was based on the volatility of peers. The Company has selected a risk-free rate based on the implied yield available on U.S. Treasury securities with a maturity equivalent to the expected term of the options. We account for forfeitures upon occurrence. Recent Accounting Pronouncements In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606), which amends certain aspects of the Board’s new revenue standard, ASU 2014-09, Revenue from Contracts with Customers. The Company does not currently generate revenue.

Stockholders Equity

Stockholders Equity	3 Months Ended
	Sep. 30, 2022
Stockholders' Equity Note [Abstract]
Stockholders Equity	Note 3 – Stockholders’ Equity Authorized Shares The Company’s Articles of Incorporation authorize the issuance of two classes of shares of stock. The total number of shares which this corporation is authorized to issue is 50,000,000 shares of $0.0001 par value common stock and 10,000,000 of $0.0001 par value preferred stock. No Common Stock Offering Immediately following the Merger, we sold 3,482,500 shares of our common stock pursuant to an initial closing of a private placement offering at a purchase price of $2.00 per share. We held a second closing on June 28, 2021 for an additional 402,500 shares of our common stock and a third and final close on July 1, 2021 for an additional 115,000. Accordingly, we sold a total of 4,000,000 shares of our common stock. The private placement offering is referred to herein as the “Offering.” The aggregate gross proceeds from the Offering during the three months ended September 30, 2021 were $230,000 (before deducting placement agent fees and expenses of the Offering of $23,070). We also paid additional offering costs totaling $45,000 during the three months ended September 30, 2021. The Offering was exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated by the SEC thereunder. The common stock in the Offering was sold to “accredited investors,” as defined in Regulation D, and was conducted on a “reasonable best efforts” basis. Issued and Vested Shares to Officers On October 27 th th Registration Rights Agreement The Company entered into a registration rights agreement that provides for certain liquidated damages upon the occurrence of a “Registration Event,” which is defined as the occurrence of any of the following events: (a) the Company fails to file with the Commission the Registration Statement on or before the Registration Filing Date; (b) the Registration Statement is not declared effective by the Commission on or before the Registration Effectiveness Date; (c) after the SEC Effective Date, the Registration Statement ceases for any reason to remain effective or the Holders of Registrable Securities covered thereby are otherwise not permitted to utilize the prospectus therein to resell the Registrable Securities covered thereby, except for Blackout Periods permitted herein; or (d) following the listing or inclusion for quotation on an Approved Market, the Registrable Securities, if issued and outstanding, are not listed or included for quotation on an Approved Market, or trading of the Common Stock is suspended or halted on the Approved Market, which at the time constitutes the principal markets for the Common Stock, for more than three (3) full, consecutive Trading Days (other than as a result of (A) actions or inactions of parties other than the Company or its affiliates or of the Approved Market not reasonably in the control of the Company, or (B) suspension or halt of substantially all trading in equity securities (including the Common Stock) on the Approved Market). The maximum amount of liquidated damages that may be paid by the Company shall be an amount equal to eight percent (8%) of the shares covered by the registration rights agreement. This filing covered 11,010,002 shares. The Company currently expects to satisfy all of its obligations under the Registration Agreement and does not expect to pay any damages pursuant to this agreement; therefore, no liability has been recorded.

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Sep. 30, 2022
Stock-Based Compensation [Abstract]
Stock-Based Compensation	Note 4 – Stock-Based Compensation Restricted Stock Awards During six months ended June 30, 2021, the Company sold 723,008 shares of common stock to certain individuals in exchange for future management advisory services, for discounted prices price ranging from $.0104 to $.0195 per share. The shares are subject to restrictions that allow for repurchase of the shares by the Company due to a termination of the service agreement or other certain provisions. This repurchase right declines on a pro-rata basis over vesting periods (corresponding to the service period) ranging from 2-4 years. Related to these issuances, the Company has recorded deferred stock-based compensation for the value of the shares in excess of the purchase price paid by the advisors. The stock-based compensation is expensed over the service period. For the three months ended September 30, 2022 and 2021, $166,977 and $165,162 have been amortized in the statement of operations, and $506,521 is presented as deferred compensation on the balance sheets at September 30, 2022, which is expected to be expensed in the next twelve months. In March 2022, the Company signed an agreement to issue 150,000 shares of common stock valued at $300,000 to a consultant for providing consulting services to the Company for eighteen months. For the three months ended September 30, 2022, $108,000 has been expensed in the statement of operations, and $192,000 is presented as deferred compensation on the balance sheets at September 30, 2022, which is expected to be expensed in the next twelve months. The 150,000 shares of common stock are not yet issued at September 30, 2022 and the Company recorded $300,000 as other current liability as of September 30, 2022. The following is a schedule summarizing restricted stock awards for the periods indicated: Number of Shares Weighted Outstanding at July 1, 2022 344,426 $ 1.90 Granted - - Vested (86,702 ) $ 1.90 Forfeited - - Outstanding at September 30, 2022 257,724 $ 1.90 Number of Options Weighted Outstanding at July 1, 2021 691,232 $ 1.90 Granted - - Vested (86,702 ) $ 1.90 Forfeited - - Outstanding at September 30, 2021 604,530 $ 1.90 Stock Options In July of 2021, the Company issued an option to purchase 10,000 shares of common stock to a director at a price of $2.00 per share, expiring in 10 years, and an option to purchase 10,000 shares of common stock to an advisor at a price of $2.00 per share expiring in 5 years. These options vested over periods ranging from one month to three months. In December of 2021, the Company issued options to purchase common stock to two directors in increments of 125,000 each. The options have an exercise price of $2.00, expire in 10 years, vest 12,500 options per quarter in the first year and 9,375 per quarter for the following two years. In February of 2022, the company granted 16,750 in options to one director and 15,500 to another director at a price of $2.00 per share, for committee service. These options are subject to quarterly vesting over four quarters and expire in 10 years. On February 1, 2022, the Company entered into a consulting advisory agreement which grants 2,500 options with every patent filing. On February 4, 2022, the advisor was granted 2,500 options with an exercise price of $2.00 and an expiration date of ten years. In April of 2022, the Company issued 513,000 options to purchase common stock to employees. The options have an exercise price of $2.00 and expire in 10 years with 25% vesting after one year and the remainder scheduled to vest each quarter for three years, subject to the continued status as an employee to the Company through each vesting date. The estimated weighted average fair value of the options granted for the year ended June 30, 2022 were approximately $1.50 per share. The Company estimates the fair value of each option award using the Black-Scholes option-pricing model. The Company used the following assumptions for to estimate the fair value of stock options for directors issued for the year ended June 30, 2022: Expected volatility 100% Expected term 5.0 years Dividend yield 0.00% Risk-free interest rate 1.15% - 2.41 For the three months ended September 30, 2022 and 2021, stock-based compensation expenses for options granted were $70,090 and $29,668, respectively. Unrecognized stock-based compensation expense was $761,262 and average expected recognition period was 3.0 years as of September 30, 2022. The following is a schedule summarizing employee and non-employee stock option activity for the period presented: Number of Options Weighted Aggregate Outstanding at July 1, 2022 817,750 $ 2.00 $ - Granted - - Exercised - - Expired/cancelled (120,000 ) $ 2.00 Outstanding at September 30, 2022 697,750 $ 2.00 $ - Exercisable at September 30, 2022 122,146 $ 2.00 $ - Number of Weighted Aggregate Outstanding at July 1, 2021 - $ - $ - Granted 20,000 $ 2.00 Exercised - - Expired/cancelled - $ 2.00 Outstanding at September 30, 2021 20,000 $ 2.00 $ - Exercisable at September 30, 2021 17,500 $ 2.00 $ - The aggregate intrinsic value represents the difference between the exercise price of the options and the estimated fair value of the Company’s common stock for each of the respective periods.

Facility Operating Lease

Facility Operating Lease	3 Months Ended
	Sep. 30, 2022
Facility Operating Lease [Abstract]
Facility Operating Lease	Note 5 – Facility Operating Lease On April 1, 2021, the Company commenced a 5-year operating lease for a facility in Santa Barbara, California with total lease payments of $781,813. The Company determined the lease constitutes a Right of Use (ROU) asset and has recorded the present value of the lease payments as an asset and liability per ASC 842. The value of the asset will be amortized on a straight-line basis over the 60-month period and amortization began at the start of the lease. Additionally, the lease agreement waived the first three months of rent with payments commencing July 2021. At the commencement of the lease, the net present value of the lease payments was 767,553 In addition to these lease payments, the Company is also responsible for its shares of common area operating expenses and electricity. Such expenses are considered variable costs and are not included in the measurement of the lease liability. The lease agreement also provides for the option to extend the lease for two additional sixty-month periods. The lease payments for these additional periods are not included in the lease liability amount presented on the balance sheet. The following table presents maturities of operating lease liabilities on an undiscounted basis as of September 30, 2022: Fiscal 2023 $ 121,052 Fiscal 2024 165,096 Fiscal 2025 169,224 Fiscal 2026 129,283 Total 584,655 Less imputed interest (7,891 ) Total operating lease liability 576,764 Less: current portion 158,284 Lease liability, long term $ 418,480 The lease term and the discount rate for the lease at September 30, 2022 is 3.5 years and 0.75%, respectively. The total lease payments were $40,359 and $31,593 for the three months ended September 30, 2022 and 2021, respectively. The variable costs for common area operating expenses and electricity were $103,795, and $56,803 for the three months ended September 30, 2022 and 2021, respectively. Beginning April 1, 2021, the Company began subleasing a portion of their facility. The sub-lease provides for base monthly rent of $13,013 through May 31, 2021 and $8,400 starting June 1, 2021 plus common area operating and utility costs. The sublease was amended again on May 17, 2022 to sublease a smaller portion of the property at a base rental rate of $5,200 per month effective June 1, 2022. During the three months ended September 30, 2022 and 2021, the Company recognized $31,351 and $90,352, respectively, of rental income, including reimbursement of common area operating and utility costs.

Warrants to Purchase Common Sto

Warrants to Purchase Common Stock	3 Months Ended
	Sep. 30, 2022
Warrants to Purchase Common Stock [Abstract]
Warrants to Purchase Common Stock	Note 6 – Warrants to Purchase Common Stock In connection with the Offering, the Company issued 360,000 warrants to purchase common stock to the Placement Agents. The warrants carry a term of 5 years and an exercise price of $2.00.

Subsequent Events

Subsequent Events	3 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 7 – Subsequent Events The Company has analyzed its operations subsequent to September 30, 2022 through the date these financial statements were issued, and has determined that, other than disclosed below, it does not have any material subsequent events to disclose. On November 7, 2022, the Company issued 150,000 shares of common stock to a consultant for providing consulting services to the Company. See Note 4 – Stock-Based Compensation.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited interim consolidated financial statements have been presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and the instructions to Article 8 of Regulation S-X. Accordingly, the financial statements do not include all of the information and notes required by GAAP for complete financial statements. The consolidated financial statements as of September 30, 2022 and 2021, are unaudited; however, in the opinion of management such interim condensed consolidated financial statements reflect all adjustments, consisting solely of normal recurring adjustments, necessary for a fair presentation of the results for the periods presented. The accompanying financial information should be read in conjunction with the financial statements and the notes thereto in the Company’s most recent Annual Report on Form 10-K, as filed with the Securities and Exchange Commission (the “SEC”) on September 28, 2022. The results of operations for the period presented are not necessarily indicative of the results that might be expected for future interim periods or for the full year. The summary of significant accounting policies presented below is designed to assist in understanding the Company’s financial statements. Such financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity.
Going Concern	Going Concern The Company incurred a net loss of $3,451,699 and $1,530,041 for the year ended June 30, 2022 and the three months ended September 30, 2022, respectively. In addition, the Company is in the research and development stage and has not generated revenue to date. In order to support its operations, the Company will require additional infusions of cash from the sale of equity instruments or the issuance of debt instruments, or the commencement of profitable revenue generating activities. If adequate funds are not available or are not available on acceptable terms, the Company’s ability to fund its operations, develop or enhance its sensors in the future or respond to competitive pressures would be significantly limited. Such limitations could require the Company to curtail, suspend or discontinue parts of its business plan. These conditions may raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that could result from the outcome of this uncertainty. The financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.
Basic Net Loss Per Share	Basic Net Loss Per Share Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. The number of shares prior to the merger have been restated to consider the conversion into the shares of the legal acquirer.
Use of Estimates and Assumptions	Use of Estimates and Assumptions The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
Reclassification of Prior Year Presentation	Reclassification of Prior Year Presentation Certain prior year amounts have been reclassified for consistency with the current year presentation.
Fair Value of Financial Instruments	Fair Value of Financial Instruments As defined in Financial Accounting Standards Board (“FASB”) ASC Topic No. 820, “Fair Value Measurements and Disclosures” (“ASC 820”), fair value is the price that would be received to sell an asset or paid to transfer the liability in an orderly transaction between market participants at the measurement date. In determining fair value, the Company uses the market or income approach. Based on this approach, the Company utilizes certain assumptions about the risk inherent in the inputs to the valuation technique. These inputs can be readily observable, market-corroborated or generally unobservable inputs. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. Based on the observability of the inputs used in the valuation techniques, the Company is required to provide the following information according to the fair value hierarchy. The fair value hierarchy ranks the quality and the reliability of the information used to determine fair values. As a basis for considering these assumptions, ASC 820 defines a three-tier value hierarchy that prioritizes the inputs used in the valuation methodologies in measuring fair value. Level 1 – Unadjusted quoted prices in active, accessible market for identical assets or liabilities Level 2 – Other inputs that are directly or indirectly observable in the marketplace Level 3 – Unobservable inputs which are supported by little or no market activity The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The carrying values of the Company’s cash, accounts payable, and accrued expenses approximate their fair value due to the relatively short maturity of these items.
Concentration of Risk	Concentration of Risk The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts.
Property and Equipment	Property and Equipment Property, equipment and leasehold improvements are reported at historical cost, net of accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the remaining lease term. Repairs and maintenance to these assets are charged to expense as incurred; major improvements enhancing the function and/or the asset’s useful life are capitalized. When items are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gains or losses arising from such transactions are recognized.
Intangible Assets	Intangible Assets Intangible assets are associated with the Aeluma.com domain name and are amortized on a straight-line basis over 10 years.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers cash in banks, deposits in transit, and highly liquid debt instruments purchased with original maturities of three months or less to be cash and cash equivalents. The Company’s accounts are insured by the FDIC but at times may exceed federally insured limits.
Income Taxes	Income Taxes The Company is expected to have net operating loss carryforwards that it can use to offset a certain amount of taxable income in the future. The Company is currently analyzing the amount of loss carryforwards that will be available to reduce future taxable income. The resulting deferred tax assets will be offset by a valuation allowance due to the uncertainty of its realization. The primary difference between income tax expense attributable to continuing operations and the amount of income tax expense that would result from applying domestic federal statutory rates to income before income taxes relates to the recognition of a valuation allowance for deferred income tax assets. The Company has adopted FASB ASC 740-10, “ Income Taxes” The Company will file tax returns in the U.S. federal jurisdiction and the state of California. The Company’s federal and state return form are subject to review by the taxing authorities. The Company is not currently under examination by any taxing authority, nor has it been notified of an impending examination.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation arrangements in accordance with guidance issued by the FASB, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, consultants, and directors based on estimated fair values. The Company estimates the fair value of stock-based compensation awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company’s statements of operations. The Company estimates the fair value of stock-based compensation awards using the Black-Scholes model. This model requires the Company to estimate the expected volatility and value of its common stock and the expected term of the stock options, all of which are highly complex and subjective variables. For employees and directors, the expected life was calculated based on the simplified method as described by the SEC Staff Accounting Bulletin No. 110, Share-Based Payment. For other service providers, the expected life was calculated using the contractual term of the award. The Company’s estimate of expected volatility was based on the volatility of peers. The Company has selected a risk-free rate based on the implied yield available on U.S. Treasury securities with a maturity equivalent to the expected term of the options. We account for forfeitures upon occurrence.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606), which amends certain aspects of the Board’s new revenue standard, ASU 2014-09, Revenue from Contracts with Customers. The Company does not currently generate revenue.

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
	Sep. 30, 2022
Stock-Based Compensation [Abstract]
Schedule of restricted stock awards	Number of Shares Weighted Outstanding at July 1, 2022 344,426 $ 1.90 Granted - - Vested (86,702 ) $ 1.90 Forfeited - - Outstanding at September 30, 2022 257,724 $ 1.90 Number of Options Weighted Outstanding at July 1, 2021 691,232 $ 1.90 Granted - - Vested (86,702 ) $ 1.90 Forfeited - - Outstanding at September 30, 2021 604,530 $ 1.90
Schedule of estimate the fair value of stock options	Expected volatility 100% Expected term 5.0 years Dividend yield 0.00% Risk-free interest rate 1.15% - 2.41
Schedule of summarizing employee and non-employee stock option activity	Number of Options Weighted Aggregate Outstanding at July 1, 2022 817,750 $ 2.00 $ - Granted - - Exercised - - Expired/cancelled (120,000 ) $ 2.00 Outstanding at September 30, 2022 697,750 $ 2.00 $ - Exercisable at September 30, 2022 122,146 $ 2.00 $ - Number of Weighted Aggregate Outstanding at July 1, 2021 - $ - $ - Granted 20,000 $ 2.00 Exercised - - Expired/cancelled - $ 2.00 Outstanding at September 30, 2021 20,000 $ 2.00 $ - Exercisable at September 30, 2021 17,500 $ 2.00 $ -

Facility Operating Lease (Table

Facility Operating Lease (Tables)	3 Months Ended
	Sep. 30, 2022
Facility Operating Lease [Abstract]
Schedule of maturities of operating lease liabilities	Fiscal 2023 $ 121,052 Fiscal 2024 165,096 Fiscal 2025 169,224 Fiscal 2026 129,283 Total 584,655 Less imputed interest (7,891 ) Total operating lease liability 576,764 Less: current portion 158,284 Lease liability, long term $ 418,480

The Company (Details)

The Company (Details)	3 Months Ended
	Sep. 30, 2022 shares
The Company [Abstract]
Common stock shares	1.299135853
Capital stock equal shares	4,100,000
Aggregate shares	2,500,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2022	Jun. 30, 2022
Accounting Policies [Abstract]
Net loss	$ 1,530,041	$ 3,451,699
Intangible assets amortized on straight-line basis	10 years
Unrecognized tax benefits income penalties expense	$ 0

Stockholders Equity (Details)

Stockholders Equity (Details) - USD ($)	1 Months Ended	3 Months Ended
	Oct. 27, 2020	Sep. 30, 2022	Jun. 30, 2022
Stockholders Equity (Details) [Line Items]
Common stock, shares authorized		50,000,000
Common stock, per share (in Dollars per share)		$ 0.0001	$ 0.0001
Preferred stock, share authorized		10,000,000
Preferred stock, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Preferred shares issued
Investors offering percentage		115,000%
Aggregate commission (in Dollars)		$ 4,000,000
Aggregate gross proceeds (in Dollars)		230,000
Net of offering placement agent fees and expenses (in Dollars)		23,070
Additional paid offering costs (in Dollars)		$ 45,000
Issued and vested shares, description	the Company issued 1,623,920 shares of common stock to Director and CEO Jonathan Klamkin and 1,623,920 shares of common stock to Director, interim CFO and COO, Lee McCarthy for an aggregate sum of $10,000 each. The stock purchase agreement contains a repurchase option whereby unvested shares may be repurchased by the Company, at the Company’s option, within 90 days after employee termination. 324,784 shares vested on October 27th, 2020, and the remaining 1,299,136 shares vest in equal amounts, monthly over the subsequent 4 years.
Vested shares		947,287
Unvested shares		676,633
Registration rights agreement description		The maximum amount of liquidated damages that may be paid by the Company shall be an amount equal to eight percent (8%) of the shares covered by the registration rights agreement. This filing covered 11,010,002 shares. The Company currently expects to satisfy all of its obligations under the Registration Agreement and does not expect to pay any damages pursuant to this agreement; therefore, no liability has been recorded.
Private Placement Offering [Member]
Stockholders Equity (Details) [Line Items]
Common stock offering price		3,482,500
Purchase price, per share (in Dollars per share)		$ 2
Common Stock [Member]
Stockholders Equity (Details) [Line Items]
Shares of common stock		402,500

Stock-Based Compensation (Detai

Stock-Based Compensation (Details) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2021
Stock-Based Compensation (Details) [Line Items]
Sale of common stock (in Shares)				723,008
Amortized value		$ 166,977	$ 165,162
Deferred compensation		506,521
Deferred stock based compensation	$ 150,000	150,000
Common stock value	$ 300,000
Stock based compensation		108,000
Current liability		$ 300,000
Stock based compensation expense description		the Company issued an option to purchase 10,000 shares of common stock to a director at a price of $2.00 per share, expiring in 10 years, and an option to purchase 10,000 shares of common stock to an advisor at a price of $2.00 per share expiring in 5 years. These options vested over periods ranging from one month to three months.In December of 2021, the Company issued options to purchase common stock to two directors in increments of 125,000 each. The options have an exercise price of $2.00, expire in 10 years, vest 12,500 options per quarter in the first year and 9,375 per quarter for the following two years. In February of 2022, the company granted 16,750 in options to one director and 15,500 to another director at a price of $2.00 per share, for committee service. These options are subject to quarterly vesting over four quarters and expire in 10 years. On February 1, 2022, the Company entered into a consulting advisory agreement which grants 2,500 options with every patent filing. On February 4, 2022, the advisor was granted 2,500 options with an exercise price of $2.00 and an expiration date of ten years. In April of 2022, the Company issued 513,000 options to purchase common stock to employees. The options have an exercise price of $2.00 and expire in 10 years with 25% vesting after one year and the remainder scheduled to vest each quarter for three years, subject to the continued status as an employee to the Company through each vesting date. The estimated weighted average fair value of the options granted for the year ended June 30, 2022 were approximately $1.50 per share.
Stock-based compensation expenses for options granted		$ 70,090	$ 29,668
Unrecognized stock-based compensation expense		$ 761,262
Average expected recognition period		3 years
Minimum [Member]
Stock-Based Compensation (Details) [Line Items]
Price per share (in Dollars per share)				$ 104
Vesting terms		2 years
Maximum [Member]
Stock-Based Compensation (Details) [Line Items]
Price per share (in Dollars per share)				$ 195
Vesting terms		4 years
Restricted Stock Awards [Member]
Stock-Based Compensation (Details) [Line Items]
Deferred compensation		$ 192,000

Stock-Based Compensation (Det_2

Stock-Based Compensation (Details) - Schedule of restricted stock awards - $ / shares	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022
Schedule of Restricted Stock Awards [Abstract]
Number of Shares, Outstanding beginning balance	691,232	344,426
Weighted Average Grant Date Fair Value Per Share, Outstanding beginning balance	$ 1.9	$ 1.9
Number of Shares, Outstanding ending balance	604,530	257,724
Weighted Average Grant Date Fair Value Per Share, Outstanding ending balance	$ 1.9	$ 1.9
Number of Shares, Granted
Weighted Average Grant Date Fair Value Per Share, Granted
Number of Shares, Vested	(86,702)	(86,702)
Weighted Average Grant Date Fair Value Per Share, Vested	$ 1.9	$ 1.9
Number of Shares, Forfeited
Weighted Average Grant Date Fair Value Per Share, Forfeited

Stock-Based Compensation (Det_3

Stock-Based Compensation (Details) - Schedule of estimate the fair value of stock options	3 Months Ended
	Sep. 30, 2022
Stock-Based Compensation (Details) - Schedule of estimate the fair value of stock options [Line Items]
Expected volatility	100%
Expected term	5 years
Dividend yield	0%
Minimum [Member]
Stock-Based Compensation (Details) - Schedule of estimate the fair value of stock options [Line Items]
Risk-free interest rate	1.15%
Maximum [Member]
Stock-Based Compensation (Details) - Schedule of estimate the fair value of stock options [Line Items]
Risk-free interest rate	2.41%

Stock-Based Compensation (Det_4

Stock-Based Compensation (Details) - Schedule of summarizing employee and non-employee stock option activity - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Schedule of Summarizing Employee and Non Employee Stock Option Activity [Abstract]
Number of Options, Beginning Balance	817,750
Weighted Average Exercise Price, Beginning Balance	$ 2
Aggregate Intrinsic Value, Beginning Balance
Number of Options, Granted		20,000
Weighted Average Exercise Price, Granted		$ 2
Number of Options, Exercised
Weighted Average Exercise Price, Exercised
Number of Options, Expired/cancelled	(120,000)
Weighted Average Exercise Price, Expired/cancelled	$ 2	$ 2
Number of Options, Ending balance	697,750	20,000
Weighted Average Exercise Price, Ending balance	$ 2	$ 2
Aggregate Intrinsic Value, Ending balance
Number of Options, Exercisable	122,146	17,500
Weighted Average Exercise Price, Exercisable	$ 2	$ 2
Aggregate Intrinsic Value, Exercisable

Facility Operating Lease (Detai

Facility Operating Lease (Details) - USD ($)		3 Months Ended		12 Months Ended
	Apr. 01, 2021	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022
Facility Operating Lease
Operating lease commencement, description	On April 1, 2021, the Company commenced a 5-year operating lease for a facility in Santa Barbara, California with total lease payments of $781,813.
Total lease payment		$ 40,359	$ 31,593	$ 767,553
Operating lease term		3 years 6 months
Operating lease discount rate		0.75%
Variable costs for common area operating expenses and electricity		$ 103,795	56,803
Lease description				The sub-lease provides for base monthly rent of $13,013 through May 31, 2021 and $8,400 starting June 1, 2021 plus common area operating and utility costs. The sublease was amended again on May 17, 2022 to sublease a smaller portion of the property at a base rental rate of $5,200 per month effective June 1, 2022.
Rent income		$ 31,351	$ 90,352

Facility Operating Lease (Det_2

Facility Operating Lease (Details) - Schedule of maturities of operating lease liabilities	Sep. 30, 2022 USD ($)
Schedule of Maturities of Operating Lease Liabilities [Abstract]
Fiscal 2023	$ 121,052
Fiscal 2024	165,096
Fiscal 2025	169,224
Fiscal 2026	129,283
Total	584,655
Less imputed interest	(7,891)
Total operating lease liability	576,764
Less: current portion	158,284
Lease liability, long term	$ 418,480

Warrants to Purchase Common S_2

Warrants to Purchase Common Stock (Details)	3 Months Ended
	Sep. 30, 2022
Warrants to Purcahase Common Stock [Abstract]
Warrants to purchase common stock , description	In connection with the Offering, the Company issued 360,000 warrants to purchase common stock to the Placement Agents. The warrants carry a term of 5 years and an exercise price of $2.00.

Subsequent Events (Details)

Subsequent Events (Details)	Nov. 07, 2022 shares
Subsequent Event [Member] | Common Stock [Member]
Subsequent Events (Details) [Line Items]
Shares issued	150,000